Sales and Marketing

NICE has announced it has recommended Takeda’s Adcetris (brentuximab vedotin), in combination with cyclophosphamide, doxorubicin and prednisone (CHP), for use …

Regeneron has revealed that REGN-COV2, its two-antibody vaccine for the treatment and prevention of COVID-19, has been awarded a manufacturing …

The European Commission has awarded approval to AstraZeneca and MSD’s Lynparza (olaparib) for germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer, with …

Electric car firm Tesla has announced it will be supplying mobile molecular printer capacity to German firm CureVac, and possibly …

ViiV Healthcare, the HIV specialist majority owned by GSK which also counts Shionogi and Pfizer among its shareholders, has secured …

The US government is sending significant remdesivir supplies to states that are being hit hardest by the coronavirus. Florida, Arizona …

The Florida Department of Health has issued a warning over a rare case of ‘brain-eating’ amoeba after one person has …

The World Health Organization has discontinued trials into the viability of hydroxychloroquine, lopinavir and ritonavir as COVID-19 treatments. This was …

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …

The UK Government warned when relaxing lockdown measures on 23 June that it would not hesitate to lock down any …

The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …

The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with …

The July/August 2020 issue of Pharmafocus is available to read free online now!

Drug watchdog NICE has chosen to stick with its earlier decision not to recommend Janssen’s Zytiga (abiraterone aetate), combined with …

The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for …